Arterium Corporation is a modern pharmaceutical company that created a powerful platform for the development and implementation of innovations, combining the expertise of two prominent Ukrainian enterprises: Kyivmedpreparat PJSC and Halychfarm PJSC. Bringing together a team of professionals and using state-of-the-art technologies and quality standards, Arterium pursues its mission – caring about people’s health and longer, more productive life.
The Corporation is mainly active on the Ukrainian market; in addition, representative offices of the Corporation in Russia, Belarus, Kazakhstan and Uzbekistan conduct active marketing operations on the foreign markets.
The key lines of Arterium’s activity include the manufacture, marketing and distribution of modern effective, safe and high-quality products to ensure longer and more productive life for the people. The total range of products includes over 145 medicinal products belonging to 11 out of 14 pharmacotherapeutic groups. The Company portfolio includes not only generics, but also original products, such as Thiotriazolin®, L-lysine escinate®, Tiocetam® and Urolesan®, which have gained the recognition and trust of the medical community owing to their efficacy and established quality. The efficacy of medicinal products manufactured by Arterium Corporation has been confirmed by clinical trials, including bioequivalence studies. A body of evidence conforming to contemporary international standards constitutes an essential requirement of the Company to new products.
Copyright © 2023, Arterium Corporation
